HomeNew
Latest
E-paper
Companies
Economy
Finance
Budget
Industry
Markets
External Affairs Defence Security
World News
Opinion
India News
Technology
Specials
Partner Content
Multimedia
sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
NewslettersNew
Video Gallery
WebstoriesNew
Politics
Management
Sudoku
Crossword
BS Apps
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Don’t miss the latest developments in business and finance.
Near-term growth issues and cost pressure could impact Aurobindo Pharma
While valuations are now attractive, product approvals and progress on the injectable guidance are among key long-term term triggers
NPPA vs Pharma makers: Industry body knocks Ananth Kumar's door over notice
NPPA issued show-cause notices to leading drug makers over 'suspected overcharging'
